Welcome to American Journal of Biomedical Sciences
 
  Home    Missions and Scope    Editorial Board    Instructions for Authors    Contact Us

 

 

Am. J. Biomed. Sci. 2012, 4(4), 285-306; doi: 10.5099/aj120400285
Received:29 February 2012; | Revised: 1 August 2012; | Accepted: 23 August 2012

 

Nucleophilic Mechanism of ROS/RNS Signaling in Cancer Epigenetic Modifications

 

Igor Afanas'ev*

Vitamin Research Institute, Moscow, Russia

*Corresponding Author:

Professor Igor Afanas'ev

Rua Vitorino Nemesio 48, 6.1, 2050-638

Porto, Portugal

Tel. 351-22-404-1736

E-mail: iafananizer@gmail.com

 

Abstract

 

       It has been shown that cancer is characterized by enhanced oxidative stress. Therefore reactive oxygen and nitrogen species (ROS/RNS) signaling in epigenetic modifications of cancer cells might be even more important comparing to the other pathologies. It is known that ROS/RNS can change DNA methylation through the direct interaction with DNA molecules and by affecting the levels of DNA methyltransferases. ROS/RNS signaling also plays an important role in the mechanism of acetylation/deacetylation of histones by histone acetyltransferases (HAT) and histone deacetylases (HDAC). We suggest that ROS/RNS signaling in epigenetic processes proceeds by a nucleophilic mechanism of etherification and hydrolysis where free radicals superoxide and nitric oxide manifest their nucleophilic properties. As HDAC inhibitors are effective ROS producers, the enhanced oxidative stress might be at least partly responsible for their anticancer activity as epigenetic drugs.

Keywords: ROS, RNS, Radicals, Signaling, Cancer.

Download the full article (PDF)

 


 

Publisher   |   Missions and Scope   |  Editorial Board   |  Instructions for Authors   |  Contact Us

 

© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved.